This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald.
This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Wall Street drifts as stocks continue to follow the bond market's leadWall Street is drifting in mixed trading, continuing a months-long run where it’s followed the cue of the bond market.
مصدر: latimes - 🏆 11. / 82 اقرأ أكثر »
Wall Street climbs as bond selloff eases, earnings lift moodU.S. stocks rose on Tuesday as a selloff in U.S. Treasuries eased, while upbeat forecasts from Verizon, Coca-Cola and others boosted optimism about corporate America's health in the face of slowing economy and higher inflation.
مصدر: Reuters - 🏆 2. / 97 اقرأ أكثر »
Wall Street climbs after profits at big companies top forecastsVerizon jumped 7% after saying it increased its number of broadband subscribers by 20% and earned more than analysts expected during the summer.
مصدر: latimes - 🏆 11. / 82 اقرأ أكثر »